Sanhong Liu
14PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Mar 13, 2026
Chemical Space Navigation of Nitidine Leads to the Discovery of a Novel PD-L1 Degradation Agent by Targeting CSN5 for Enhanced Antitumor Immunity.Qun Wang, Mengmeng Guo, Yujia Song
|Oct 20, 2025
Cordycepin Targets HRD1 to Promote Cancer Cell PD-L1 Ubiquitin-Proteasome Degradation and Increase Antitumor Immunity.Xiangxin Geng, Minchen Cai, Hongmei Hu
|Sep 22, 2025
Marine Natural Product Chagosendine C Induces Cuproptosis in Colorectal Cancer Cells by Targeting FDX1.Xiaoyu Tao, Hongru Wang, Qun Wang
|Dec 25, 2024
Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation.Hongmei Hu, Qun Wang, Dianping Yu
|Nov 05, 2024
Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer.Saisai Tian, Mengting Xu, Xiangxin Geng
|Jun 28, 2024
5,7,4'-Trimethoxyflavone triggers cancer cell PD-L1 ubiquitin-proteasome degradation and facilitates antitumor immunity by targeting HRD1.Jianhua Xia, Mengting Xu, Hongmei Hu
Pageof 3
